Reduce Blend – Capsules (60 Count)
Reduce Blend – Capsules (60 Count) SLU-PP-332 (250 mcg) / BAM15 (50 mg) SLU-PP-332 (250 mcg) and BAM15 are experimental compounds studied for metabolic health and obesity management. SLU-PP-332 functions as an ERR agonist that acts as an exercise mimetic, enhancing fatty acid oxidation and mitochondrial function. BAM15 is a mitochondrial uncoupler that increases energy expenditure and improves glycemic control.
Research Use Only Disclaimer
FOR RESEARCH USE ONLY This product is not intended for human or animal use.Not for medical, diagnostic, therapeutic, metabolic, mitochondrial, or consumption purposes.No dosage, administration, or biological outcome claims are made or implied.Use is restricted to qualified laboratory research environments only.
❓Frequently Asked Questions
Is the Reduce blend approved for medical or dietary use?
No. This product is supplied strictly for laboratory research purposes.
Does this product include a Certificate of Analysis (COA)?
Yes. Every batch includes a third-party verified COA.
Why is this product formulated as a compound blend?
The blend format supports research involving compound compatibility, formulation stability, and analytical evaluation.
Can this compound be used in humans or animals?
No. It is not approved for use in living systems.
How is this product classified?
It is classified solely as a research compound blend, not a drug, supplement, or therapeutic agent.